Abstract

Introduction Measles still remains as one of the major causes of childhood morbidity and mortality in developing countries. In 2013, it was responsible for 2% of total deaths in children under five years of age. Measles related pneumonia (MRP) is the commonest cause of death in children with measles It may be associated with acute respiratory distress syndrome (ARDS) and pleural effusion (PE). We describe a case of severe measles related pneumonia with bilateral pleural effusion and ARDS in a 10 month old girl, successfully treated with high dose of methyl prednisolone, vitamin A and intravenous (IV) immunoglobulin during the outbreak in 2013.

Highlights

  • 315,000/cu mm with an erythrocyte sedimentation childhood morbidity and mortality in developing countries[1]

  • Related pneumonia (MRP) is the commonest cause of death in children with measles[3]. It may be associated with acute respiratory distress syndrome (ARDS)[4] and pleural effusion (PE)[5]

  • Physical successfully treated with high dose of methyl examination on admission to medical intensive care unit (MICU) revealed prednisolone, vitamin A and intravenous (IV)

Read more

Summary

Case Reports

Management of severe measles related pneumonia, acute respiratory distress syndrome and pleural effusion with intravenous methyl prednisolone, immunoglobulin and oral vitamin A. Child was managed with IV cefuroxime, IV cloxacillin and oral erythromycin with a presumptive diagnosis of MRP related pneumonia (MRP) is the commonest cause of death in children with measles[3]. It may be associated with acute respiratory distress syndrome (ARDS)[4] and pleural effusion (PE)[5]. The patient was severe measles related pneumonia with bilateral pleural effusion and ARDS in a 10 month old girl, intubated and transferred to the medical intensive care unit (MICU) on 7th day of the illness. Bandaranaike Specialized Children's Hospital, Peradeniya, Sri Lanka, 3Registrar in Paediatrics, General Hospital, Jaffna, Sri Lanka

Open Access Article published under the Creative
Findings
Discussion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.